Table 6.
SCA case no. | LH/FSH | ACTH | ACTH/LH colocalized | α-GSU | Tpit (%) | NeuroD1 (%) | SF-1 (%) | ACTH/SF-1 colocalized | DAX-1 (%) |
---|---|---|---|---|---|---|---|---|---|
1 | − | + | n/a | + | − | +++ | +++ | + | +++ |
2 | − | + | n/a | − | − | +++ | +++ | n/a | +++ |
3 | − | + | n/a | − | − | +++ | +++ | − | +++ |
4 | + | + | − | + | + | +++ | +++ | + | +++ |
5 | − | + | n/a | + | − | +++ | ++ | n/a | +++ |
6 | − | + | n/a | + | + | +++ | +++ (nuc) | + | +++ |
7 | − | + | n/a | + | + | +++ | +++ | + | +++ |
8 | + | + | − | + | − | +++ | +++ | + | +++ |
9 | + | + | + | − | + | +++ | +++ (nuc) | + | +++ |
10 | − | + | n/a | + | + | +++ | ++ | + | +++ |
10 (1st recurrence) | − | + | n/a | n/a | − | n/a | n/a | n/a | ++ |
10 (2nd recurrence) | − | + | n/a | − | − | +++ | +++ | + | +++ |
11 | + | + | n/a | n/a | − | +++ | +++ (nuc) | + | +++ |
11 (1st recurrence) | + | + | + | + | − | +++ | +++ (nuc) | + | +++ |
12 | − | + | n/a | + | + | +++ | +++ | + | +++ |
13 | + | + | n/a | + | − | +++ | ++ (nuc) | n/a | +++ |
14 | − | + | n/a | − | − | +++ | +++ | − | +++ |
15 | − | + | n/a | + | + | +++ | + | n/a | +++ (cyto) |
16 | + | + | n/a | + | − | +++ | ++ | + | +++ |
17 | − | + | n/a | + | + | +++ | ++ | + | +++ |
18 | + | + | − | − | − | +++ | +++ | + | +++ |
Shown is scoring for each immunostained transcription factor
Staining for LH, FSH, ACTH, and α-GSU was not quantified and are scored as either present (+) or absent (−)
Staining for Tpit, NeuroD1, and DAX-1 is nuclear unless otherwise noted. Staining for SF-1 is both nuclear and cytoplasmic unless otherwise noted. For quantification of Tpit, NeuroD1, SF-1, and DAX-1, + = <25%; ++ = 25–50%; +++ = 50–100% percent positive staining according to incidence of positively stained cells
% percentage of cells, Nuc nuclear, Cyto cytoplasmic, n/a not available or not applicable